121 related articles for article (PubMed ID: 17292607)
1. A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.
DeCarr LB; Buckholz TM; Milardo LF; Mays MR; Ortiz A; Lumb KJ
Bioorg Med Chem Lett; 2007 Apr; 17(7):1916-9. PubMed ID: 17292607
[TBL] [Abstract][Full Text] [Related]
2. Identification of selective neuropeptide Y2 peptide agonists.
DeCarr LB; Buckholz TM; Coish PD; Fathi Z; Fisk SE; Mays MR; O'Connor SJ; Lumb KJ
Bioorg Med Chem Lett; 2007 Jan; 17(2):538-41. PubMed ID: 17055726
[TBL] [Abstract][Full Text] [Related]
3. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
[TBL] [Abstract][Full Text] [Related]
4. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.
Lumb KJ; DeCarr LB; Milardo LF; Mays MR; Buckholz TM; Fisk SE; Pellegrino CM; Ortiz AA; Mahle CD
J Med Chem; 2007 May; 50(9):2264-8. PubMed ID: 17425299
[TBL] [Abstract][Full Text] [Related]
5. Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice.
Shechter Y; Tsubery H; Mironchik M; Rubinstein M; Fridkin M
FEBS Lett; 2005 Apr; 579(11):2439-44. PubMed ID: 15848185
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists.
Balasubramaniam A; Joshi R; Su C; Friend LA; James JH
Peptides; 2007 Feb; 28(2):235-40. PubMed ID: 17204349
[TBL] [Abstract][Full Text] [Related]
8. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
9. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour.
Scott V; Kimura N; Stark JA; Luckman SM
J Neuroendocrinol; 2005 Jul; 17(7):452-7. PubMed ID: 15946163
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
12. NPY2 receptor activation in the dorsal vagal complex increases food intake and attenuates CCK-induced satiation in male rats.
Huston NJ; Brenner LA; Taylor ZC; Ritter RC
Am J Physiol Regul Integr Comp Physiol; 2019 Apr; 316(4):R406-R416. PubMed ID: 30726118
[TBL] [Abstract][Full Text] [Related]
13. PYY transgenic mice are protected against diet-induced and genetic obesity.
Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
[TBL] [Abstract][Full Text] [Related]
14. Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivity.
Pedersen SL; Holst B; Vrang N; Jensen KJ
J Pept Sci; 2009 Nov; 15(11):753-9. PubMed ID: 19739125
[TBL] [Abstract][Full Text] [Related]
15. Obesity: keeping hunger at bay.
Schwartz MW; Morton GJ
Nature; 2002 Aug; 418(6898):595-7. PubMed ID: 12167841
[No Abstract] [Full Text] [Related]
16. Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active.
Germain N; Minnion JS; Tan T; Shillito J; Gibbard C; Ghatei M; Bloom S
Peptides; 2013 Jan; 39():6-10. PubMed ID: 23123314
[TBL] [Abstract][Full Text] [Related]
17. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP
Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086
[TBL] [Abstract][Full Text] [Related]
18. Glyco-scan: varying glycosylation in the sequence of the peptide hormone PYY3-36 and its effect on receptor selectivity.
Pedersen SL; Steentoft C; Vrang N; Jensen KJ
Chembiochem; 2010 Feb; 11(3):366-74. PubMed ID: 20049760
[TBL] [Abstract][Full Text] [Related]
19. PYY3-36 as an anti-obesity drug target.
Boggiano MM; Chandler PC; Oswald KD; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Schindler M; Arndt K; Rudolf K; Mark M; Schoelch C; Joost HG; Klaus S; Thöne-Reineke C; Benoit SC; Seeley RJ; Beck-Sickinger AG; Koglin N; Raun K; Madsen K; Wulff BS; Stidsen CE; Birringer M; Kreuzer OJ; Deng XY; Whitcomb DC; Halem H; Taylor J; Dong J; Datta R; Culler M; Ortmann S; Castañeda TR; Tschöp M
Obes Rev; 2005 Nov; 6(4):307-22. PubMed ID: 16246216
[TBL] [Abstract][Full Text] [Related]
20. Peptide YY induces characteristic meal patterns of aged mice.
Mogami S; Yamada C; Fujitsuka N; Hattori T
Horm Behav; 2017 Nov; 96():62-68. PubMed ID: 28916138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
